Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic acid infusion rate and postoperative nausea/vomiting in adolescent idiopathic scoliosis surgery
ChiCTR2500107188Phase 4Not yet recruiting
- Sponsor
- West China Tianfu Hospital
- Start
- Aug 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of tranexamic acid in adolescent idiopathic scoliosis (AIS) (3 arms), sponsored by West China Tianfu Hospital. Primary endpoints: Postoperative nausea and Postoperative vomiting. Planned start Aug 2025; status: not yet recruiting.
02
Drugs
tranexamic acid
03
Conditions
adolescent idiopathic scoliosis (AIS)
Beyond the preview
Go deeper on ChiCTR2500107188.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500107188.